Clara Monleón is an accomplished professional in market access, health policy, and health economics with a robust background in the pharmaceutical and biotech sectors. They have held pivotal roles such as Global Patient Value and Access Lead at Takeda Oncology from 2020 to 2022 and Global Senior Director of Market Access at Urovant Sciences, Inc. from 2022 to 2023. Clara has contributed significantly to the development of innovative reimbursement strategies and health economics studies, showcasing expertise in optimizing pricing and access in various markets. Currently, Clara serves as the Global Value & Access Strategy Lead at Amgen, continuing to leverage their extensive knowledge in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices